New radiation strategy aims to stop ewing sarcoma from coming back
NCT ID NCT07188532
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way of giving radiation therapy for Ewing sarcoma, a rare bone and soft tissue cancer. The radiation dose is tailored to each patient's tumor size and biology, with higher doses given over a shorter time. The goal is to reduce the chance of the cancer returning at the original tumor site. The study includes about 141 people aged 2 and older with large tumors (8 cm or bigger) or other high-risk features.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Arizona
NOT_YET_RECRUITINGPhoenix, Arizona, 85054, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can engineered immune cells tackle childhood sarcoma?
- A simple blood test may reveal how ewing sarcoma responds to therapy
- Targeted radiation zaps childhood brain tumors in early trial
- New immunotherapy targets genetic flaw in rare childhood cancers
- Engineered immune cells take on Hard-to-Treat sarcomas